Mark Cowley

Mark Cowley is a computational biologist and Associate Professor who leads the Computational Biology Group at Children's Cancer Institute in Australia.12 He specializes in genomics and precision medicine, focusing on improving outcomes for children with cancer through advanced data analysis.13

Key Roles and Expertise

• Deputy Director (Enabling Platforms and Collaboration) at Children's Cancer Institute1
• Head of the Luminesce Alliance Data Enabling Platform1
• Co-Head of the ACRF Childhood Cancer Liquid Biopsy Program1
• President of Australasian Genomic Technologies Association (AGTA)1

Research Focus

Cowley's work centers on translational bioinformatics, particularly:

• Pioneering whole genome sequencing to uncover molecular bases of childhood cancers, rare diseases, and other genetic conditions1
• Developing software solutions for genome biology and precision medicine programs1
• Investigating the impact of non-coding mutations in children with cancer12

Career Highlights

• Joined Children's Cancer Institute in 2018 to establish the Computational Biology Group1
• His early research contributed to three of the first clinically accredited whole-genome-sequencing-based pathology tests worldwide1
• Developed over 20 software solutions for genome biology and precision medicine1
• Plays a key role in the Zero Childhood Cancer clinical trial, bridging molecular data and improved health outcomes12

Education

• PhD in Bioinformatics, Transcriptomics, and Genetics from UNSW Australia (2008)3
• BSc (Hons I) in Bioinformatics from the University of Sydney (2003)3

Mark Cowley's work aims to improve cancer treatment through personalized medicine, leveraging computational approaches to analyze vast amounts of genomic data for better patient outcomes.23